Atıf Formatları
Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. Taghizade Et Al. , "Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.," The Journal of allergy and clinical immunology , 2023

Taghizade, N. Et Al. 2023. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.. The Journal of allergy and clinical immunology .

Taghizade, N., Babayeva, R., Kara, A., Karakus, I. S., Catak, M. C., Bulutoglu, A., ... Haskologlu, Z. S.(2023). Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.. The Journal of allergy and clinical immunology .

Taghizade, Nigar Et Al. "Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.," The Journal of allergy and clinical immunology , 2023

Taghizade, Nigar Et Al. "Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.." The Journal of allergy and clinical immunology , 2023

Taghizade, N. Et Al. (2023) . "Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.." The Journal of allergy and clinical immunology .

@article{article, author={Nigar Taghizade Et Al. }, title={Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.}, journal={The Journal of allergy and clinical immunology}, year=2023}